Skip to content

Viatris VTRS Price / book

Price / book at other companies

Pfizer logo
PfizerPFE
1.8×+0.2×
Cencora logo
CencoraCOR
18×-35.2×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
0.0×
Roivant Sciences logo
Roivant SciencesROIV
4.4×+2.8×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
3.9×-0.5×
Biogen logo
BiogenBIIB
1.4×+0.3×

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.32B+49.6%
Enterprise value$31.13B+17.7%
P/S1.3×+0.4×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

Based on the most recent quarter.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's price / book?
Viatris (VTRS) reported price / book of 1.1× in Q1 2026.
How has Viatris's price / book changed year-over-year?
Viatris's price / book increased by 59.7% year-over-year, from 0.7× to 1.1×.
What is the long-term trend for Viatris's price / book?
Over 4 years (2021 to 2025), Viatris's price / book has grown at a -0.8% compound annual growth rate (CAGR), from 3.2× to 3.1×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.